Ascendis Pharma A/S

NASDAQ: ASND · Real-Time Price · USD
197.97
5.93 (3.09%)
At close: Aug 15, 2025, 3:59 PM
200.00
1.03%
After-hours: Aug 15, 2025, 06:18 PM EDT

Ascendis Pharma A/S Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-341.68M -378.08M -426.49M -489.52M -501.57M -481.45M -601.99M -608.72M -568.61M -583.19M -481.84M -393.23M -446.28M -383.58M -416.48M -457.87M -418.43M
Depreciation & Amortization
17.78M 17.71M 18.22M 18.59M 18.84M 18.91M 18.57M 18.34M 18.09M 17.96M 17.59M 16.86M 16.09M 15.39M 14.1M 12.59M 11.17M
Stock-Based Compensation
103.74M 95.47M 85.15M 76.37M 70.25M 66.66M 64.63M 60.98M 57.9M 64.18M 64.45M 64.2M 63.72M 66.83M 67.07M 64.2M 61.3M
Other Working Capital
99.3M 110.95M 22.9M 32.51M 23.81M -2.21M -23.57M -18.07M -13.53M -5.45M -16.56M -46.42M -56.84M -28.78M -30.2M -2.97M 26.41M
Other Non-Cash Items
-39.13M 54.53M 123.57M 162.62M 99.49M 21M 38.29M 26.66M -10.01M 18.6M -37.11M -81.05M -6.41M -67.01M -18.9M 39.37M 33.51M
Deferred Income Tax
2.11M 4.61M 9.32M 8.94M 8.51M 7.3M 6.86M 6.05M 6.43M 5.38M -86K 87K 65K -367K -270K -295K -333K
Change in Working Capital
38.24M -108.64M -79.46M -115.29M -125.64M -99.79M -92.93M -44M -15.76M -18.62M -40.34M -82.89M -94M -48.91M -30.2M -2.97M 26.41M
Operating Cash Flow
-218.93M -306.2M -261.49M -330.08M -421.9M -467.36M -566.58M -540.69M -511.95M -495.7M -477.32M -476.01M -466.82M -417.65M -384.67M -344.97M -286.38M
Capital Expenditures
-1.93M -1.43M -981K -1.45M -1.56M -2.44M -6.29M -8.47M -11.76M -14.49M -15.5M -23.64M -23.5M -24.23M -24.66M -18.65M -19.97M
Cash Acquisitions
n/a n/a 4.28K 51.63K 51.63K 51.63K 9.52M 9.17M 15.08M 18.93M 9.45M 9.75M 3.85M -10.19M -9.23M -9.23M -9.23M
Purchase of Investments
n/a n/a -4.28K -51.63K -51.63K -51.63K -53.05M -124.14M -187.53M -213.84M -299.33M -239.38M -212.91M -226.04M -284.9M -380.66M -343.75M
Sales Maturities Of Investments
-1K 7.35M 13.94M 37.09M 84.49M 288.87M 338.27M 403.52M 427.38M 280.53M 255.91M 210.42M 190.69M 149.88M 248.91M 206M 154.47M
Other Investing Acitivies
950K 8.3M 8.27M 8.36M 54.81M 259.18M 249.7M 249.96M 202.39M -5.54M -103.2M -71.77M -56.99M -86.88M 20.34M 125.27M -122.79M
Investing Cash Flow
-982K 6.88M 13.91M 36.63M 82.98M 286.47M 279.03M 270.9M 233.84M 61.73M -49.39M -43.07M -41.92M -110.58M -69.79M -65.8M -315.18M
Debt Repayment
122.51M 122.79M 119.48M 125.3M 125.6M 125.82M 130.3M -8.28M -8.15M 496.93M 497.16M 497.06M 498.04M -6.43M -6.18M -5.84M -5.62M
Common Stock Repurchased
-28.79M n/a -1.81M -1.81M -1.81M -1.81M -2K -1K -151K -105.31M -126.91M -126.91M -126.76M -21.61M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
294.47M 301.85M 318.31M 27.97M 27.82M 8.47M 11.4M 6.54M 6.63M 5.15M 4.35M 7.44M 9.94M 11.54M 9.21M -26.59M -29.39M
Financial Cash Flow
407.48M 443.93M 437.79M 153.27M 153.42M 134.29M 141.7M -1.74M -1.66M 396.77M 374.8M 745.48M 749.1M 351.39M 382.33M 596.39M 603.79M
Net Cash Flow
197.68M 167.38M 184.25M -135.53M -181.04M -52.6M -167.06M -278.17M -254.36M -1.5M -84.61M 287.85M 260.6M -138.25M -70.51M 143.93M -39.33M
Free Cash Flow
-220.86M -307.62M -262.47M -331.53M -423.45M -469.8M -572.86M -549.16M -523.71M -510.19M -492.83M -499.65M -490.31M -441.88M -409.33M -363.62M -306.35M